Sepracor Announces First Quarter 2007 Results - Business Wire (press release)
XOPENEX ® brand levalbuterol HCl Inhalation Solution — XOPENEX Inhalation Solution is a short-acting beta-agonist indicated for the treatment or prevention ...
Tue Apr 24 04:06:45 -0400 2007
Sepracor Announces First Quarter 2007 Results - PharmaLive.com (press release)
XOPENEX(R) brand levalbuterol HCl Inhalation Solution -- XOPENEX Inhalation Solution is a short-acting beta-agonist indicated for the treatment or ...
Tue Apr 24 08:21:13 -0400 2007